Auto Summaries

Last updated: 2025 Apr 18

Total hit(s): 10933

S.No.
1	40183376	A plain language summary of the available safety data for the BNT162b2 COVID-19 vaccine: development, approval, and surveillance of use.	N/A	Expert Rev Vaccines	2025 Apr 4	4.37	1
2	40227322	Correction: Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19.	N/A	Intensive Care Med	2025 Apr 14	8.61	1
3	40220519	The link between norepinephrine administration and pressure injury risk in patients with COVID-19-related ARDS - Letter on Mahmoodpoor et al.	N/A	Intensive Crit Care Nurs	2025 Apr 11	1.85	1
4	40220520	Clarifications and insights on the link between norepinephrine administration and pressure ulcer risk in patients with COVID-19-related ARDS - Response to Cai et al.	N/A	Intensive Crit Care Nurs	2025 Apr 11	1.85	1
5	40169371	COVID-19 outcomes in patients with pre-existing interstitial lung disease: A national multi-center registry-based study in China.	N/A	Chin Med J (Engl)	2025 Apr 1	1.053	1
6	40187801	New COVID-19 Vaccine Cost and Access Barriers Add Challenges to Immunizing Post-Acute and Long-Term Care Staff.	N/A	J Am Med Dir Assoc	2025 Apr	5.02	1
7	40059397	Correction to: "The Mediating and Moderating Role of Recovery Experience Between Occupational Stress and Turnover Intention in Nurses Caring for Patients With COVID-19".	N/A	J Clin Nurs	2025 Mar 9	1.93	1
8	40148711	Correction: Effect of early and later prone positioning on outcomes in invasively ventilated COVID-19 patients with acute respiratory distress syndrome: analysis of the prospective COVID-19 critical care consortium cohort study.	N/A	Ann Intensive Care	2025 Mar 28	3.85	1
9	40155913	Correction to: Epidemiology, ventilation management and outcomes of COVID-19 ARDS patients versus patients with ARDS due to pneumonia in the Pre-COVID era.	N/A	Respir Res	2025 Mar 28	3.89	1
10	40140097	Rapid clinical effects of convalescent plasma therapy in severe COVID-19 acute respiratory distress syndrome (ARDS).	N/A	Intensive Care Med	2025 Mar 26	8.61	1
11	39955238	The effects of COVID-19 on professional football: Clinical management, player performance, and vaccination impact.	N/A	J Sci Med Sport	2025 Feb 5	3.54	1
12	39952804	Retraction notice to "Personal protective equipment-derived pollution during Covid-19 era: A critical review of ecotoxicology impacts, intervention strategies, and future challenges" [Sci. Total Environ. 887(2023) 164164].	N/A	Sci Total Environ	2025 Feb 13	5.9	1
13	39954314	Exploring mortality representation and the impact of COVID-19 in Modena: insights from "An ECG-based machine-learning approach for mortality risk assessment in a large European population".	N/A	J Electrocardiol	2025 Feb 10	1.2	1
14	39764846	An Investigation Into the Clinical Characteristics and Management Strategies for Patients With Lymphoma and Concomitant COVID-19.	N/A	Am J Ther	2025 Jan-Feb 01	2.6	1
15	39762150	Investigation of the factors contributing to symptoms worsening in elderly care-facility residents with dementia: Difficulties encountered in dealing with COVID-19 clusters.	N/A	Geriatr Gerontol Int	2025 Jan 6	4.4	1
16	39900094	The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant.	N/A	Lancet Infect Dis	2025 Jan 31	21.77	1
17	39743454	Corrigendum to "What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?" [Int. Immunopharmacol. 105 (2022) 108542].	N/A	Int Immunopharmacol	2025 Jan 27	3.38	1
18	39884145	A prospective design is required to calculate the epidemiological parameters of patients with SARS-CoV-2-vaccination associated GBS.	N/A	Clin Neurol Neurosurg	2025 Jan 26	1.7	1
19	39838238	Correction: Identification and validation of respiratory subphenotypes in patients with COVID-19 acute respiratory distress syndrome undergoing prone position.	N/A	Ann Intensive Care	2025 Jan 22	3.85	1
20	39792303	Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference.	N/A	Drug Saf	2025 Jan 10	3.64	1
21	39393042	Comment on: "COVID-19 vaccine hesitancy among the Chinese elderly: A multi-stakeholder qualitative study".	N/A	Hum Vaccin Immunother	2024 Dec 31	4.7	1
22	38353267	Ethical concerns regarding heterologous COVID-19 vaccine administration.	N/A	Hum Vaccin Immunother	2024 Dec 31	4.7	1
23	39706844	Author Correction: Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes.	N/A	Nat Commun	2024 Dec 20	11.8	1
24	39690164	Author Correction: Pulmonary diffusing capacity among individuals recovering from mild to moderate COVID-19: a cross-sectional study.	N/A	Sci Rep	2024 Dec 17	4.12	1
25	39676571	The effect of SARS-CoV-2 infection and COVID-19 vaccination during pregnancy on neonatal outcomes.	N/A	Epidemiol Infect	2024 Dec 16	2.01	1